Tuesday, February 14, 2017 6:25:35 PM
Then pile on this latest news about the criminal investigation, which really sucks. Even if the company can escape any legal penalty for wrong-doing, if their clinical process is questionable, you can forget about FDA approval based on current results. This pushes the time-frame for KIT-302 even further out, which really chisels away at the value of warrants.
And credibility? This had been one of the company's strong points moving ahead- the line-up of seasoned industry and FDA-experienced pros who knew how to get an NDA over the line. That's all up in smoke now IMO. Reputation is everything: whether officials in the company acted criminally or not, the damage has been done.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM